Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer (ABC) patients: Results on safety and efficacy—An Italian multicenter experience.

Stefania Eufemia Lutrino, Saverio Cinieri, Caterina Fontanella et al.|Journal of Clinical Oncology|2016

Cited by 3